Netarsudil: Honeycomb hypertrophy.

Two patients, a 12-year-old boy and a 75-year-old woman, developed honeycomb hypertrophy while being treated with netarsudil for ocular conditions. The boy had a history of corticosteroid-induced ocular hypertension and the woman had neovascular glaucoma. Both patients experienced resolution of their symptoms after discontinuing netarsudil treatment. The article provides a concise description of the cases without making any judgments or assumptions. [Extracted from the article]